EODData

MEMBERSHIP REGISTER LOG IN

FRA, P731: MEDEXUS PHARMACEUTIC.

05 Sep 2025
LAST:

1.830

CHANGE:
 0.01		OPEN:
1.830		HIGH:
1.830		ASK:
0.000		VOLUME:
214
CHG(%):
0.54		PREV:
1.840		LOW:
1.830		BID:
0.000		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
05 Sep 251.8301.8301.8301.830214
04 Sep 251.8401.8401.8401.840214
03 Sep 251.8401.8401.8401.840214
02 Sep 251.8301.8301.8301.830214
01 Sep 251.8301.8301.8301.830214
29 Aug 251.8701.8701.8701.870214
28 Aug 251.8701.8701.8701.870214
27 Aug 251.7101.7101.7101.710214
26 Aug 251.7001.7001.7001.700214
25 Aug 251.7101.7101.7101.710214

COMPANY PROFILE

Name:MEDEXUS PHARMACEUTIC.
About:Medexus Pharmaceuticals Inc. operates as a pharmaceutical company in Canada and the United States. The company focuses on various therapeutic areas comprising allergy, dermatology, hematology, oncology, rheumatology, and rare diseases. Its primary products include IXINITY, an intravenous recombinant factor IX therapeutic for use in patients with hemophilia B; Rasuvo and Metoject, a formulation of methotrexate designed to treat rheumatoid arthritis and other auto-immune diseases; Rupall, a prescription allergy medication; GRAFAPEX, an injection to treat allogeneic hematopoietic stem cell transplantation in adult and pediatric patients, acute myeloid leukemia (AML), and myelodysplastic syndrome (MDS); and Gleolan, an optical imaging agent for patients with glioma as an adjunct for the visualization of malignant tissue during surgery. The company's products portfolio also includes Cuvposa, a glycopyrrolate oral solution; Naproxen, a Pediapharm naproxen suspension; Otixal, a ciprofloxacin and flucinolone acetonide; Trispan, a triamcinolone hexacetonide injectable suspension; and Trecondyv, a bifunctional alkylating agent for use as part of a conditioning treatment for patients undergoing allogeneic hematopoietic stem cell transplantation. In addition, it offers over the counter products comprising Nyda, a topical treatment indicated for the eradication of head lice; Relaxa, an osmotic laxative to treat occasional constipation in adults; Oralvisc to reduce joint pain and enhance joint function in osteoarthritis of the knee; and Calcia Calcium and vitamin D products. The company was formerly known as Pediapharm Inc. and changed its name to Medexus Pharmaceuticals Inc. in December 2018. Medexus Pharmaceuticals Inc. was founded in 2018 and is based in Toronto, Canada.
Sector:Healthcare
Address:10 King Street East, Toronto, ON, Canada, M5C 1C3
Website:https://www.medexus.com
ISIN:CA58410Q2036

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

P/E Ratio:92.00
Price to Book:1.31
Price to Sales:0.58
EBITDA:16.48M
Shares:32.26M
Market Cap:59.03M

TECHNICAL INDICATORS

MA5:1.83
MA10:1.80
MA20:1.73
MA50:1.74
MA100:1.74
MA200:1.86
STO9:76.47
STO14:78.95
RSI14:57.14
WPR14:-21.05
MTM14:0.12
ROC14:0.07
ATR:0.04
Week High:1.87
Week Low:1.83
Month High:1.87
Month Low:1.56
Year High:3.53
Year Low:1.23
Volatility:55.49

RECENT SPLITS

Date Ratio
19 Dec 20181-15